ConductScience.org, home

Paper8317294

Gaucher disease. Enzymology, genetics, and treatment.

Grabowski GA. Adv Hum Genet, 1993. Cited by 95 papers, by iCite.

Cite this record

ConductScience Library. Gaucher disease. Enzymology, genetics, and treatment. Papers, record 8317294. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8317294

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Gaucher disease. Enzymology, genetics, and treatment.
PubMed
Journal
Adv Hum Genet
PubMed
Year
1993
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
95
iCite
Relative citation ratio, by iCite
3.08
iCite
Revised in PubMed
2022-03-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grabowski GAG A

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gaucher DiseaseMajor topic
Animals
Carbohydrate Sequence
Humans
Molecular Sequence Data

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.

PMIDTitleJournalYearIn PapersSource
36499264Glucosylsphingosine (Lyso-Gb1): An Informative Biomarker in the Clinical Monitoring of Patients with Gaucher Disease.Int J Mol Sci2022https://conductscience.org/library/papers/36499264PubMed
30363648A Meta-Analysis of GBA-Related Clinical Symptoms in Parkinson's Disease.Parkinsons Dis2018https://conductscience.org/library/papers/30363648PubMed
29719368Pharmacotherapy of Gaucher Disease: Current and Future Options.P T2018https://conductscience.org/library/papers/29719368PubMed
29527153Integrated Genetic Analysis of Racial Differences of Common GBA Variants in Parkinson's Disease: A Meta-Analysis.Front Mol Neurosci2018https://conductscience.org/library/papers/29527153PubMed
28966932Frequency of GBA variants in autopsy-proven multiple system atrophy.Mov Disord Clin Pract2017https://conductscience.org/library/papers/28966932PubMed
28933363The Spectrum of Neurological Manifestations Associated with Gaucher Disease.Diseases2017https://conductscience.org/library/papers/28933363PubMed
27827870Ceramide as a Target of Marine Triterpene Glycosides for Treatment of Human Myeloid Leukemia.Mar Drugs2016https://conductscience.org/library/papers/27827870PubMed
27688581Gaucher Disease in Two Siblings.Med J Armed Forces India2008https://conductscience.org/library/papers/27688581PubMed
27182231Gaucher disease in Iraqi children (Clinical, diagnostic & therapeutic aspects).Pak J Med Sci2016https://conductscience.org/library/papers/27182231PubMed
27083470Cellular Uptake of Glucocerebrosidase in Gaucher Patients Receiving Enzyme Replacement Treatment.Clin Pharmacokinet2016https://conductscience.org/library/papers/27083470PubMed
26312487Activation of p38 Mitogen-Activated Protein Kinase in Gaucher's Disease.PLoS One2015https://conductscience.org/library/papers/26312487PubMed
26141627Demographic Studies from a National Gaucher Disease Screening Program.J Genet Couns1998https://conductscience.org/library/papers/26141627PubMed
25997737Role of Sphingolipids and Metabolizing Enzymes in Hematological Malignancies.Mol Cells2015https://conductscience.org/library/papers/25997737PubMed
25968608Impact of imiglucerase supply constraint on the therapeutic management and course of disease in French patients with Gaucher disease type 1.Orphanet J Rare Dis2015https://conductscience.org/library/papers/25968608PubMed
25386355Hemorrhagic aspects of Gaucher disease.Rambam Maimonides Med J2014https://conductscience.org/library/papers/25386355PubMed
24070122Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease.Orphanet J Rare Dis2013https://conductscience.org/library/papers/24070122PubMed
22646221Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase.J Med Chem2012https://conductscience.org/library/papers/22646221PubMed
22033823A high throughput glucocerebrosidase assay using the natural substrate glucosylceramide.Anal Bioanal Chem2012https://conductscience.org/library/papers/22033823PubMed
21626386Epidemiology and etiology of Parkinson's disease: a review of the evidence.Eur J Epidemiol2011https://conductscience.org/library/papers/21626386PubMed
20980259Molecular basis of reduced glucosylceramidase activity in the most common Gaucher disease mutant, N370S.J Biol Chem2010https://conductscience.org/library/papers/20980259PubMed

See all 30 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8317294

GET https://conductscience.org/api/papers/v1/8317294/cited_by?page=2